https://www.zacks.com/stock/news/2220511/abbvie-abbv-q4-earnings-beat-raises-sales-view-for-key-drugs?cid=CS-ZC-FT-analyst_blog|earnings_article-2220511
Feb 02, 2024 - AbbVie???s (ABBV) fourth-quarter earnings and sales beat estimates. Management hikes the 2027 forecast for new immunology drugs to more than $27 billion.
zc:-2017038614076952031
0
https://www.fool.com/investing/2024/02/03/7-dividend-stocks-that-pay-me-more-than-500-per-mo/?source=iedfolrf0000001
Feb 03, 2024 - These stocks pay safe, reliable, and growing dividends.
0
fool:-8143902548400009636
0
https://www.zacks.com/commentary/2223994/top-research-reports-for-johnson-johnson-walt-disney-uber?cid=CS-ZC-FT-research_daily-2223994
Feb 09, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), The Walt Disney Company (DIS) and Uber Technologies, Inc. (UBER).
zc:8028952784333983336
0
https://www.zacks.com/stock/news/2235489/j-j-jnj-secures-full-fda-nod-for-rybrevant-in-lung-cancer?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2235489
Mar 04, 2024 - The approval is based on data from a late-stage study wherein treatment with J&J's (JNJ) Rybrevant plus chemotherapy reduced the disease-progression risk or death by 61% in certain NSCLC patients.
zc:4163593556888934980
0
https://www.zacks.com/stock/news/2236717/bayer-bayry-q4-earnings-top-crop-science-unit-drives-revenues?cid=CS-ZC-FT-analyst_blog|earnings_article-2236717
Mar 06, 2024 - Bayer (BAYRY) beats earnings estimates in the fourth quarter of 2023, primarily driven by increased sales of Crop Science and Pharmaceuticals products.
zc:4521125375410249720
0
https://www.zacks.com/stock/news/2238322/pharma-stock-roundup-nvo-s-new-obesity-pill-data-rhhby-azn-s-pipeline-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-2238322
Mar 08, 2024 - Novo Nordisk???s (NVO) early-stage data on a new weight loss pill, amycretin, shows it can outperform Wegovy. FDA approves J&J???s (JNJ) Rybrevant for first-line use.
zc:8954737857558499476
0
https://www.zacks.com/commentary/2240062/top-stock-reports-for-unitedhealth-johnson-johnson-oracle?cid=CS-ZC-FT-research_daily-2240062
Mar 13, 2024 - Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ) and Oracle Corporation (ORCL).
zc:-1350128636118921996
0
https://www.zacks.com/stock/news/2242442/johnson-johnson-jnj-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2242442
Mar 18, 2024 - Johnson & Johnson (JNJ) closed the most recent trading day at $156.76, moving -0.9% from the previous trading session.
zc:-8487695140326696076
0
https://www.zacks.com/stock/news/2242244/bristol-myers-bmy-abecma-gets-odac-votes-for-label-expansion?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2242244
Mar 18, 2024 - Bristol Myers' (BMY) Abecma gets eight out of 11 votes from the FDA's ODAC for patients with triple-class exposed relapsed or refractory multiple myeloma in earlier lines of therapy.
zc:-85513231562097745
0
https://www.fool.com/investing/2024/04/06/can-a-new-ceo-fix-boeing/?source=iedfolrf0000001
Apr 06, 2024 - We also talk with e.l.f. Beauty CEO Tarang Amin about how the company is succeeding.
0
fool:-5644472562978032325
0